Artikler med mandater om offentlig tilgang - Stefan N. ConstantinescuLes mer
Ikke tilgjengelige noe sted: 3
Oncogenic activation of MPL/thrombopoietin receptor by 17 mutations at W515: implications for myeloproliferative neoplasms
JP Defour, I Chachoua, C Pecquet, SN Constantinescu
Leukemia 30 (5), 1214-1216, 2016
Mandater: National Fund for Scientific Research, Belgium
Targets in MPNs and potential therapeutics
G Levy, C Mambet, C Pecquet, S Bailly, V Havelange, CC Diaconu, ...
International review of cell and molecular biology 366, 41-81, 2022
Mandater: National Fund for Scientific Research, Belgium
A phenotypic screen for small-molecule inhibitors of constitutively active mutant Thrombopoietin receptor implicated in myeloproliferative neoplasms
A Ngo, A Zhufang Koay, C Pecquet, C C Diaconu, Y Ould-Amer, Q Huang, ...
Combinatorial Chemistry & High Throughput Screening 19 (10), 824-833, 2016
Mandater: National Fund for Scientific Research, Belgium
Tilgjengelige et eller annet sted: 107
Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths
P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ...
Science immunology 6 (62), eabl4340, 2021
Mandater: US National Institutes of Health, Howard Hughes Medical Institute, National …
New mutations and pathogenesis of myeloproliferative neoplasms
W Vainchenker, F Delhommeau, SN Constantinescu, OA Bernard
Blood, The Journal of the American Society of Hematology 118 (7), 1723-1735, 2011
Mandater: National Institute of Health and Medical Research, France
NetPath: a public resource of curated signal transduction pathways
K Kandasamy, SS Mohan, R Raju, S Keerthikumar, GSS Kumar, ...
Genome biology 11, 1-9, 2010
Mandater: US National Institutes of Health
X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19
T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ...
Science immunology 6 (62), eabl4348, 2021
Mandater: US National Institutes of Health, Howard Hughes Medical Institute, National …
Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants
I Chachoua, C Pecquet, M El-Khoury, H Nivarthi, RI Albu, C Marty, ...
Blood, The Journal of the American Society of Hematology 127 (10), 1325-1335, 2016
Mandater: Austrian Science Fund, National Fund for Scientific Research, Belgium …
Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo
PS Woll, U Kjällquist, O Chowdhury, H Doolittle, DC Wedge, S Thongjuea, ...
Cancer cell 25 (6), 794-808, 2014
Mandater: Swedish Research Council, UK Medical Research Council, National Institute …
Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms
JD Milosevic Feenstra, H Nivarthi, H Gisslinger, E Leroy, E Rumi, ...
Blood, The Journal of the American Society of Hematology 127 (3), 325-332, 2016
Mandater: Austrian Science Fund, National Fund for Scientific Research, Belgium …
Calreticulin mutants in mice induce an MPL-dependent thrombocytosis with frequent progression to myelofibrosis
C Marty, C Pecquet, H Nivarthi, M El-Khoury, I Chachoua, M Tulliez, ...
Blood, The Journal of the American Society of Hematology 127 (10), 1317-1324, 2016
Mandater: Austrian Science Fund, National Fund for Scientific Research, Belgium …
Advances in covalent kinase inhibitors
A Abdeldayem, YS Raouf, SN Constantinescu, R Moriggl, PT Gunning
Chemical Society Reviews 49 (9), 2617-2687, 2020
Mandater: Austrian Science Fund, Canadian Institutes of Health Research, Natural …
Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancer
B Wingelhofer, HA Neubauer, P Valent, X Han, SN Constantinescu, ...
Leukemia 32 (8), 1713-1726, 2018
Mandater: US National Institutes of Health, Austrian Science Fund, National Fund for …
Presence of atypical thrombopoietin receptor (MPL) mutations in triple-negative essential thrombocythemia patients
X Cabagnols, F Favale, F Pasquier, K Messaoudi, JP Defour, JC Ianotto, ...
Blood, The Journal of the American Society of Hematology 127 (3), 333-342, 2016
Mandater: National Institute of Health and Medical Research, France
Tuning cytokine receptor signaling by re-orienting dimer geometry with surrogate ligands
I Moraga, G Wernig, S Wilmes, V Gryshkova, CP Richter, WJ Hong, ...
Cell 160 (6), 1196-1208, 2015
Mandater: US National Institutes of Health, Howard Hughes Medical Institute, National …
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ...
Proceedings of the National Academy of Sciences 119 (21), 2022
Mandater: Fundação de Amparo à Pesquisa do Estado de São Paulo, US National Institutes …
The Jak2 V617F oncogene associated with myeloproliferative diseases requires a functional FERM domain for transformation and for expression of the Myc and Pim proto-oncogenes
G Wernig, JR Gonneville, BJ Crowley, MS Rodrigues, MM Reddy, ...
Blood, The Journal of the American Society of Hematology 111 (7), 3751-3759, 2008
Mandater: US National Institutes of Health
JAK inhibitors for the treatment of myeloproliferative neoplasms and other disorders
W Vainchenker, E Leroy, L Gilles, C Marty, I Plo, SN Constantinescu
F1000Research 7, 82, 2018
Mandater: National Fund for Scientific Research, Belgium, National Institute of Health …
Infection Exposure Is a Causal Factor in B-cell Precursor Acute Lymphoblastic Leukemia as a Result of Pax5-Inherited Susceptibility
A Martin-Lorenzo, J Hauer, C Vicente-Duenas, F Auer, ...
Cancer discovery 5 (12), 1328-1343, 2015
Mandater: Government of Spain
Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: relevance for disease evolution
X Cabagnols, JP Defour, V Ugo, JC Ianotto, P Mossuz, J Mondet, ...
Leukemia 29 (1), 249-252, 2015
Mandater: National Fund for Scientific Research, Belgium, National Institute of Health …
Informasjon om publisering og finansiering fastsettes automatisk av et datamaskinprogram